Novo Nordisk A/S/ DK0062498333 /
2024-05-13 10:45:53 AM | Chg. +22.05 | Volume | Bid10:45:54 AM | Ask10:45:55 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
906.05DKK | +2.49% | 581,753 Turnover: 227 mill. |
905.90Bid Size: 22 | 906.10Ask Size: 26 | 3109.36 bill.DKK | 1.04% | 48.48 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 18.67 DKK | 52.35% |
EPS Diluted: | - DKK | 52.37% |
Revenues per Share: | 67.62 DKK | 33.20% |
Book Value per Share: | 31.02 DKK | 29.53% |
Cash Flow per Share: | 31.71 DKK | 40.11% |
Dividend per Share: | 9.40 DKK | 51.61% |
Total | in mill. | |
Revenues: | 232,261.00 DKK | 31.26% |
Net Income: | 83,683.00 DKK | 50.71% |
Operating Cash Flow: | 108,908.00 DKK | - |
Cash and Cash Equivalents: | 14,392.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 48.48 | 37.39 |
P/S Ratio: | 13.39 | 10.32 |
P/BV ratio: | 29.18 | 22.50 |
P/CF Ratio: | 28.55 | 22.02 |
PEG: | 0.93 | 0.71 |
Earnings Yield: | 2.06% | 2.67% |
Dividend Yield: | 1.04% | 1.35% |
Market Capitalization | ||
Market Capitalization: | 3109.36 bill. DKK | 2397.97 bill. DKK |
Free Float Market Cap.: | - DKK | - DKK |
Market Cap. / Employee: | 48.34 mill. DKK | 37.28 mill. DKK |
Shares Outstanding: | 3.44 bill. |
Profitability
Gross Profit Margin: | 84.60% |
EBIT Margin: | 44.16% |
Net Profit Margin: | 36.03% |
Return on Equity: | 78.53% |
Return on Assets: | 26.61% |
Financial Strength
Liquidity I / Cash Ratio: | 8.48% |
Liquidity II / Quick Ratio: | 46.66% |
Liquidity III / Current Ratio: | 82.31% |
Debt / Equity Ratio: | 195.12% |
Dynam. Debt / Equity Ratio: | 190.92% |
Efficiency
Employees: | 64,319 |
Personal Expenses / Employee: | - DKK |
Revenues / Employee: | 3,611,079.15 DKK |
Net Income / Employee: | 1,301,061.89 DKK |
Total Assets / Employee: | 4,889,472.78 DKK |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | DKK |